Washington University, St. Louis
Program Director: Dominic Reeds, MD
Washington University School of Medicine
660 S. Euclid Avenue, Campus Box 8031
St. Louis, MO 63110
The Pilot and Feasibility Program provides modest research support for a limited time (usually one to two years) to enable eligible investigators to explore the feasibility of a concept related to the mission of the NORC and generate sufficient data to pursue it through other funding mechanisms (e.g. R01).
The pilot and feasibility studies are intended to:
- Provide support for new investigators seeking to test a new hypothesis or idea related to nutrition/obesity.
- Allow exploration of possible innovative new directions for established investigators already working in the nutrition/obesity field.
- Stimulate investigators from other areas to participate in nutrition/obesity research.
Pilot and feasibility study support is not intended for large projects by established investigators that would otherwise be submitted as separate research grant applications, nor is it intended to provide bridging support. Pilot and feasibility funds are also not intended to support or supplement ongoing funded research of an investigator.
Annie Mayer Bridwell, PhD, DVM: Diabetic alterations to NETosis as mediators of heightened susceptibility to M. tuberculosis (renewal)
Rita Brookheart, PhD: Obesity-associated skeletal muscle dysfunction and regenerative capacity after injury (renewal-diversity supplement)
Daniel Ferguson, PhD: Role of microglial mitochondria pyruvate carrier in diet-induced obesity
Julia Lopez, PhD, MPH, LCSW: Community-based cognitive behavioral lifestyle therapy to improve diabetes-related health outcomes in an underserved Latinx population (renewal)
Andrew Lutkewitte, PhD: Mechanisms of adipocyte-specific Lipin 1 regulation of hepatic metabolism (renewal)
Kathleen Markan-Klostermann, PhD: Mechanisms underlying cellular senescence in obesity
Arin Oestreich, PhD: Metabalo-epigenetic programming of fetal chondrocytes by maternal obesity
Nathaniel York, PhD: Hyperglycemia induced hyperexcitability: A novel role for KATP in the progression of type 2 diabetes